FDA Accepts New Drug Application for Vascular Ehlers-Danlos Drug
https://pixabay.com/en/drugs-capsule-pill-medicine-2031442/

FDA Accepts New Drug Application for Vascular Ehlers-Danlos Drug

According to a story by MarketScreener, pharmaceutical company Acer Therapeutics Inc. has submitted a New Drug Application (NDA) for its vascular Ehlers-Danlos syndrome (vEDS) drug Edsivo. The NDA was granted…

Continue Reading FDA Accepts New Drug Application for Vascular Ehlers-Danlos Drug

Potential Gene Therapy for Limb Girdle Muscular Dystrophy Type 2D Granted Orphan Drug Designation

Limb Girdle Muscular Dystrophy Type 2D (LGMD2D), also called alpha-sarcoglycanopathy, is a form of muscular dystrophy which is caused by a defected SGCA gene. It causes the body to lose function of…

Continue Reading Potential Gene Therapy for Limb Girdle Muscular Dystrophy Type 2D Granted Orphan Drug Designation

Fast Track Designation Granted to Potential Therapy for Sickle Cell Disease

CRISPR Therapeutics and Vertex Pharmaceuticals have been collaborating to develop a new treatment option for Sickle Cell Disease. It's called CTX001, a type of stem cell therapy. This drug has…

Continue Reading Fast Track Designation Granted to Potential Therapy for Sickle Cell Disease
Close Menu